Treatment with 2-pyridone PIM1 inhibitor was able to significantly downregulate Notch1, Notch2, CTNNB1, and CDC42 in SARS-CoV-2-infected cells at 24 h post-infection (p-value < 0.001). This evidence concerns the gene CDC42 and infection.